Your Pulse On America: Live And Unfiltered
President Trump on Monday signed an executive order asking drugmakers to voluntarily reduce the prices of key medicines in the United States. But the order cites no obvious legal authority to mandate lower prices. The order said the administration would consider taking regulatory actions or importing drugs from other countries in the future if drugmakers…
President Trump will sign an executive order on Monday aimed at lowering some drug prices in the United States by aligning them with what other wealthy countries pay, he said on Truth Social on Sunday evening. The proposal he described, which alone cannot shift federal policy, is what he calls a “most favored nation” pricing…
Tens of thousands of Americans will soon be forced by their heath insurance to switch from one popular obesity drug to another that produces less weight loss. It is the latest example of the consequences of secret deals between drugmakers and middlemen, known as pharmacy benefit managers, that are hired by employers to oversee prescription…
WeightWatchers, a 62-year-old health and wellness company that has faced stiff competition from new weight-loss drugs and programs, filed for bankruptcy on Tuesday in an effort to reduce its debt by more than $1 billion while it expands its telehealth business. In its heyday, WeightWatchers shaped how millions of people in the United States and…
The share of U.S. imports from China in the first quarter of the year fell to its lowest point in over 20 years, as the high tariffs President Trump has put on Chinese goods clamped down on trade. U.S. imports from China reached $102.7 billion in the first three months of the year, data released…
Health Secretary Robert F. Kennedy Jr. announced a plan that would require placebo-controlled studies for all new vaccines, surprising some experts who noted that such testing already routinely takes place. In a statement, Andrew Nixon, a spokesman for the Department of Health and Human Services, said that “all new vaccines will undergo safety testing in…
Insulin, heart treatments and antibiotics have flowed freely across many borders for decades, exempt from tariffs in a bid to make medicine affordable. But that could soon change. For months, President Trump has been promising to impose higher tariffs on pharmaceuticals as part of his plan to reorder the global trading system and bring key…
President Trump signed an executive order on Tuesday outlining a series of actions intended to lower drug prices, including helping states import drugs from Canada. The policies were more modest than proposals to reduce drug prices that Mr. Trump offered in his first term. And one of his new directives could increase drug prices. It…
President Trump’s decision to move a step closer to imposing tariffs on imported medicines poses considerable political risk, because Americans could face higher prices and more shortages of critical drugs. The Trump administration filed a federal notice on Monday saying that it had begun an investigation into whether imports of medicines and pharmaceutical ingredients threaten…
Stocks inched higher in early trading on Tuesday, as the Trump administration’s chaotic tariff rollout continues to spur volatility in the markets. The S&P 500 opened up 0.5 percent, and the technology-heavy Nasdaq also gained slightly. President Trump’s whipsawing tariff policies are still driving sentiment on Wall Street, especially in sectors facing the threat of…